⌕
Smith & Nephew · SNN · NYSE
Tenet 61 · Solid
Compare
$30.51−1.49%At closeTenet 61 · Solid
$30.51−0.46 (−1.49%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD

Smith & Nephew (SNN) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

The percentage on each card is SNN's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

● MarketBeatNov 8, 2026 · 15:14 ET
Smith & Nephew SNATS Q3 Earnings Call Highlights

Smith & Nephew SNATS NYSE: SNN lowered its full-year revenue and trading profit outlook after continued weakness in its U.S. knee and hip businesses tempered otherwise stronger third-quarter growth.…

SNN 0.0% todayRead at source ↗
● Seeking AlphaNov 6, 2026 · 12:49 ET
Smith & Nephew: Sluggish Growth And Shifting Outlook Now Make It Less Attractive (Rating Downgrade)

Smith & Nephew faces credibility challenges after a profit warning and lowered guidance, despite recent share price gains. SNN cut the full-year underlying revenue growth forecast to 3% and halved expected trading profit…

SNN 0.0% todayRead at source ↗
● Seeking AlphaNov 4, 2026 · 11:24 ET
Smith & Nephew plc (SNN) Q3 2026 Sales/Trading Call Transcript

Smith & Nephew plc (SNN) Q3 2026 Sales/Trading Call Transcript…

SNN 0.0% todayRead at source ↗
● Zacks Investment ResearchOct 8, 2026 · 14:20 ET
Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets

SNN expands CARTIHEAL's reach across 12 European markets, backed by five-year clinical data and strong momentum in its Sports Medicine Joint Repair business.…

SNN 0.0% todayRead at source ↗
● GlobeNewsWireOct 6, 2026 · 04:00 ETCOMPANY'S OWN WORDS
Smith+Nephew lancia in Europa CARTIHEAL™ AGILI-C™, l'innovativo impianto per la riparazione della cartilagine, che sarà presentato all'ICRS Summit in Portogallo.

Smith+Nephew (LSE: SN, NYSE: SNN) azienda di tecnologia medica, annuncia il lancio commerciale in Europa di CARTIHEAL AGILI-C, l'innovativo impianto per la riparazione della cartilagine. La tecnologia sarà presentata all…

SNN 0.0% todayRead at source ↗
● GlobeNewsWireOct 6, 2026 · 04:00 ETCOMPANY'S OWN WORDS
Smith+Nephew lanza en Europa el innovador implante de reparación de cartílago CARTIHEAL™ AGILI-C™, que será protagonista en el Congreso ICRS de Portugal

Smith+Nephew (LSE: SN, NYSE: SNN), compañía global de tecnología médica, anuncia hoy que su innovador implante de reparación de cartílago CARTIHEAL AGILI-C ya está disponible para su comercialización en Europa. El implan…

SNN 0.0% todayRead at source ↗
● GlobeNewsWireOct 6, 2026 · 04:00 ETCOMPANY'S OWN WORDS
Smith+Nephew's revolutionary CARTIHEAL™ AGILI-C™ Cartilage Repair Implant launches in Europe; to be featured at ICRS Summit in Portugal

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that its innovative CARTIHEAL AGILI-C Cartilage Repair Implant is now commercially available in Europe. The CARTIHEAL Implant will t…

SNN 0.0% todayRead at source ↗
● Zacks Investment ResearchSep 30, 2026 · 14:55 ET
Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care

SNN expands its trauma portfolio with the EVOS PELVIC System, targeting complex pelvic and acetabular fracture procedures in the United States.…

SNN 0.0% todayRead at source ↗
● Defense WorldSep 25, 2026 · 04:21 ET
Smith & Nephew SNATS (NYSE:SNN) Reaches New 52-Week Low – Time to Sell?

Smith and Nephew SNATS, Inc. (NYSE: SNN - Get Free Report) shares reached a new 52-week low on Wednesday. The company traded as low as $27.05 and last traded at $27.0610, with a volume of 130820 shares traded. The stock …

SNN 0.0% todayRead at source ↗
● GlobeNewsWireSep 23, 2026 · 12:01 ET
MULTIMEDIA UPDATE: Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management

The All-in-one system combines plates, cannulated screws and specialized instrumentation to streamline complex pelvic surgery Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the la…

SNN 0.0% todayRead at source ↗
● GlobeNewsWireSep 23, 2026 · 11:11 ETCOMPANY'S OWN WORDS
Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management

The All-in-one system combines plates, cannulated screws and specialized instrumentation to streamline complex pelvic surgery Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the la…

SNN 0.0% todayRead at source ↗
● GlobeNewsWireSep 21, 2026 · 10:00 ETCOMPANY'S OWN WORDS
Smith+Nephew to showcase leading shoulder technologies for joint repair and reconstruction at ICSES 2026

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will highlight a suite of advanced solutions for shoulder repair and reconstruction at the International Congress for Shoulder an…

SNN 0.0% todayRead at source ↗
● AccesswireSep 16, 2026 · 05:45 ETCOMPANY'S OWN WORDS
Smith & Nephew Plc Announces Result of Cash Tender Offer for 2030 Bonds

Smith+Nephew announces results of its cash tender offer for up to $250 million of its outstanding 2.032% notes due 2030 LONDON, GB / ACCESS Newswire / September 16, 2026 / Smith+Nephew, the global medical technology comp…

SNN 0.0% todayRead at source ↗
● AccesswireSep 15, 2026 · 18:00 ETCOMPANY'S OWN WORDS
Smith & Nephew Plc Announces Pricing of Cash Tender Offer for 2030 Bonds

Smith+Nephew announces pricing of its cash tender offer for up to $250 million of its outstanding 2.032% notes due 2030 LONDON, UK / ACCESS Newswire / September 15, 2026 / Smith+Nephew, the global medical technology comp…

SNN 0.0% todayRead at source ↗
● GuruFocusSep 14, 2026 · 19:58 ET
Is It Too Late to Buy Smith & Nephew PLC (SNN) After 3.3% Rally? GF Value Says Undervalued

On September 14, 2026, Smith and Nephew PLC (SNN) shares rose 3.3% to a current price of $28.40. The stock has experienced a 52-week range between $27.23 and $37.…

SNN 0.0% todayRead at source ↗
● Defense WorldSep 9, 2026 · 01:21 ET
Smith & Nephew SNATS (NYSE:SNN) Hits New 52-Week Low Following Analyst Downgrade

Smith and Nephew SNATS, Inc. (NYSE: SNN - Get Free Report) hit a new 52-week low on Wednesday after Bank of America downgraded the stock from a buy rating to a neutral rating. The company traded as low as $27.57 and last…

SNN 0.0% todayRead at source ↗
● AccesswireSep 8, 2026 · 08:40 ETCOMPANY'S OWN WORDS
Smith & Nephew Plc Announces Cash Tender Offer for 2030 Bonds Up To $250m

Smith+Nephew announces cash tender offer for up to $250 million of its outstanding 2.032% notes due 2030 LONDON, UK / ACCESS Newswire / September 8, 2026 / Smith+Nephew, the global medical technology company (the "Compan…

SNN 0.0% todayRead at source ↗
● Proactive InvestorsSep 4, 2026 · 11:52 ET
Smith & Nephew keeps Jefferies 'buy' despite H2 growth scepticism

Smith & Nephew PLC (LSE:SN) drew a cautious assessment from Jefferies on Friday, with the broker maintaining its 'buy' rating despite investor scepticism over execution and a reduced financial year 2026 guidance. Shares …

SNN 0.0% todayRead at source ↗
● Proactive InvestorsSep 2, 2026 · 09:14 ET
Panmure Liberum cuts Smith & Nephew target price after disappointing results and CFO exit

Panmure Liberum has cut its target price for Smith & Nephew PLC (LSE:SN), the medical devices maker, to 1120p from 1250p, while maintaining its 'hold' rating. The broker said it still struggled to make a credible investm…

SNN 0.0% todayRead at source ↗
● Proactive InvestorsAug 25, 2026 · 11:22 ET
UBS cuts Smith & Nephew target on competitive threats to three franchises

UBS has cut its price target on Smith & Nephew PLC (LSE:SN) to 1,120p from 1,300p, warning that even the medical device group's recently reduced guidance for this year remains at risk. The neutral rating is unchanged, wi…

SNN 0.0% todayRead at source ↗
● Defense WorldAug 25, 2026 · 05:17 ET
BlackRock Inc. Invests $505.32 Million in Smith & Nephew SNATS, Inc. $SNN

BlackRock Inc. acquired a new stake in shares of Smith and Nephew SNATS, Inc. (NYSE: SNN) in a recent quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC)…

SNN 0.0% todayRead at source ↗
● Zacks Investment ResearchAug 19, 2026 · 14:00 ET
SNN Advances Surgical Robotics Through Imperial College Partnership

Smith+Nephew's five-year Imperial College London partnership targets less invasive robotic surgery and could speed research into clinical use.…

SNN 0.0% todayRead at source ↗
● Proactive InvestorsAug 19, 2026 · 03:46 ET
Smith & Nephew shares slip on CFO's departure

Smith & Nephew PLC (LSE:SN) share prices weakened around 3% after the company announced that chief financial officer John Rogers will leave the company at the end of September. The medical technology group's shares fell …

SNN 0.0% todayRead at source ↗
● Proactive InvestorsAug 19, 2026 · 03:46 ET
Smith & Nephew drops 3.5% as finance chief quits

Smith & Nephew PLC (LSE:SN) shares fell 3.5% to 1,071.84p early on Wednesday after finance chief John Rogers stepped down from the medical technology company's board with immediate effect. Rogers will officially leave hi…

SNN 0.0% todayRead at source ↗
● Zacks Investment ResearchAug 18, 2026 · 12:06 ET
Smith+Nephew Launches FLOW FLEXTEND COBLATION Wand for Hip Surgery

SNN launches the FLOW FLEXTEND COBLATION Wand, offering adjustable-angle access and precise tissue removal in complex joint procedures.…

SNN 0.0% todayRead at source ↗
● GlobeNewsWireAug 18, 2026 · 03:01 ETCOMPANY'S OWN WORDS
Smith+Nephew and Imperial College London launch centre to accelerate innovation in surgical robotics

Smith+Nephew and Imperial College London have launched a five-year partnership to deliver research for robotic surgery for musculoskeletal conditions.…

SNN 0.0% todayRead at source ↗

No upcoming events in the feeds.

NVDA29−0.4%
WDAY4−5.8%
BBW3−2.6%

Article counts from the last market-wide feed page, across every symbol we track and not just SNN · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.